• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000-2009 年 HIV 阳性个体中的侵袭性肺炎球菌病。

Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.

机构信息

HIVand STI Department, Health Protection Agency, London, UK.

出版信息

AIDS. 2012 Jan 2;26(1):87-94. doi: 10.1097/QAD.0b013e32834dcf27.

DOI:10.1097/QAD.0b013e32834dcf27
PMID:22008657
Abstract

OBJECTIVES

To examine invasive pneumococcal disease (IPD) incidence, the impact of the 7-valent pneumococcal conjugate vaccines (PCV7s) programme on the distribution of Streptococcus pneumoniae serotypes and risk factors for IPD among HIV-positive adults.

METHODS

We analysed adults (aged ≥15 years) reported to the HIV and IPD national datasets in England and Wales (2000-2009). Through data-linkage, changes in IPD incidence and serotype distribution were examined. Risk factors for IPD among HIV-positive adults were assessed using a case-control study.

RESULTS

Among 63,109 HIV-positive adults, 951 were co-infected with IPD. The average annual incidence of IPD was 245 episodes per 100,000 HIV-positive adults and 246 of 100,000 among those aged 15-44 years. Incidence was higher among those not on antiretroviral therapy (ART) (281 of 100,000) and those with severe immunosuppression (563 of 100,000). Among 9283 adults aged 15-44 at IPD diagnosis, 2.4% were living with undiagnosed HIV. The proportion of IPD episodes in HIV-positive adults with serotypes covered by PCV7 was 23% in 2009, a 54% proportional reduction compared with pre-PCV7 (2000-2006); the reduction in adults of unknown HIV status was 70%. The proportion of IPD episodes among HIV-positive adults caused by serotypes covered by PCV13 was 61%. Significant risk factors for IPD in multivariate analysis included older aged (≥65 years), a lower nadir CD4 cell count and no previous ART.

CONCLUSION

An HIV test should be offered and recommended to adults aged 15-44 years without other obvious IPD risk factors. Our study provides an evidence base to policy makers regarding the use of the new PCV13 in HIV-positive adults.

摘要

目的

研究侵袭性肺炎球菌病(IPD)的发病率,7 价肺炎球菌结合疫苗(PCV7)计划对肺炎链球菌血清型分布的影响,以及艾滋病毒阳性成年人发生 IPD 的危险因素。

方法

我们分析了英格兰和威尔士艾滋病毒和 IPD 国家数据集报告的成年人(年龄≥15 岁)(2000-2009 年)。通过数据链接,检查了 IPD 发病率和血清型分布的变化。采用病例对照研究评估艾滋病毒阳性成年人发生 IPD 的危险因素。

结果

在 63109 名艾滋病毒阳性成年人中,有 951 人合并感染 IPD。每 100000 名艾滋病毒阳性成年人中,IPD 的年平均发病率为 245 例,年龄在 15-44 岁的成年人中为 246 例。未接受抗逆转录病毒治疗(ART)的成年人(每 100000 人中 281 例)和严重免疫抑制的成年人(每 100000 人中 563 例)的发病率更高。在诊断为 IPD 的 9283 名年龄在 15-44 岁的成年人中,有 2.4%的人患有未确诊的 HIV。在 2009 年,艾滋病毒阳性成年人中由 PCV7 涵盖血清型引起的 IPD 发生率为 23%,与 PCV7 前(2000-2006 年)相比,这一比例下降了 54%;对于 HIV 状态未知的成年人,这一比例下降了 70%。艾滋病毒阳性成年人中由 PCV13 涵盖血清型引起的 IPD 发生率为 61%。多变量分析中的显著危险因素包括年龄较大(≥65 岁)、最低 CD4 细胞计数较低和从未接受过 ART。

结论

对于没有其他明显 IPD 危险因素的 15-44 岁成年人,应提供并建议进行 HIV 检测。我们的研究为决策者提供了关于在艾滋病毒阳性成年人中使用新的 PCV13 的证据基础。

相似文献

1
Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.2000-2009 年 HIV 阳性个体中的侵袭性肺炎球菌病。
AIDS. 2012 Jan 2;26(1):87-94. doi: 10.1097/QAD.0b013e32834dcf27.
2
Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.23 价肺炎球菌多糖疫苗对英格兰和威尔士老年人侵袭性肺炎球菌病的影响和效果。
Vaccine. 2012 Nov 6;30(48):6802-8. doi: 10.1016/j.vaccine.2012.09.019. Epub 2012 Sep 18.
3
Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.高效抗逆转录病毒治疗时代法国HIV感染成人侵袭性肺炎球菌病的危险因素
Int J STD AIDS. 2014 Dec;25(14):1022-8. doi: 10.1177/0956462414528316. Epub 2014 Mar 27.
4
Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.在西班牙加泰罗尼亚使用新型结合疫苗之前导致侵袭性肺炎球菌病的血清型和克隆。
J Infect. 2011 Aug;63(2):151-62. doi: 10.1016/j.jinf.2011.06.002. Epub 2011 Jun 12.
5
Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.HIV 感染者侵袭性肺炎球菌病患者的死亡率和抗生素耐药趋势。
HIV Med. 2009 Sep;10(8):488-95. doi: 10.1111/j.1468-1293.2009.00717.x. Epub 2009 May 6.
6
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.侵袭性肺炎球菌病负担和欧洲儿童中肺炎链球菌分离株血清型分布:7 价肺炎球菌结合疫苗的影响以及对未来结合疫苗的考虑。
Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22.
7
The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.人类免疫缺陷病毒感染的泰国儿童中肺炎球菌结合疫苗的免疫原性和安全性。
Vaccine. 2011 Aug 11;29(35):5886-91. doi: 10.1016/j.vaccine.2011.06.072. Epub 2011 Jul 3.
8
Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.1989 - 2006年人类免疫缺陷病毒感染儿童中的侵袭性肺炎球菌疾病
Pediatr Infect Dis J. 2008 Oct;27(10):886-91. doi: 10.1097/INF.0b013e3181734f8f.
9
Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.肺炎球菌结合疫苗时代白山阿帕契人侵袭性肺炎球菌病的流行病学变化
Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.
10
Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.犹他州成年人在 7 价肺炎球菌结合疫苗时代末期的肺炎链球菌血清型。
Vaccine. 2011 Nov 15;29(49):9123-6. doi: 10.1016/j.vaccine.2011.10.009. Epub 2011 Oct 14.

引用本文的文献

1
Pneumococcal vaccine hyporesponsiveness in people living with HIV: A narrative review of immunological mechanisms and insights from minimally invasive lymph node sampling.HIV感染者中肺炎球菌疫苗低反应性:免疫机制的叙述性综述及微创淋巴结采样的见解
Hum Vaccin Immunother. 2025 Dec;21(1):2503602. doi: 10.1080/21645515.2025.2503602. Epub 2025 May 15.
2
Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study.立即或延迟抗逆转录病毒治疗前后包括结核病在内的严重细菌感染风险:一项多中心、前瞻性队列研究。
Int J Infect Dis. 2025 Jul;156:107911. doi: 10.1016/j.ijid.2025.107911. Epub 2025 Apr 21.
3
Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population.
马拉维艾滋病毒感染者的实验性肺炎球菌携带情况:关键高危人群中的首个受控人类感染模型。
Wellcome Open Res. 2024 Jan 3;9:2. doi: 10.12688/wellcomeopenres.19949.1. eCollection 2024.
4
COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancy.COVID-19 疫苗在 HIV 感染者中的接种情况:识别与疫苗犹豫相关的特征。
Sci Rep. 2023 Nov 23;13(1):20610. doi: 10.1038/s41598-023-47106-8.
5
Vaccination and Trust in the National Health System among HIV+ Patients: An Italian Cross-Sectional Survey.HIV阳性患者对国家卫生系统的疫苗接种与信任:一项意大利横断面调查。
Vaccines (Basel). 2023 Aug 2;11(8):1315. doi: 10.3390/vaccines11081315.
6
Awareness and Hesitancy of COVID-19 and other Vaccines among People Living with HIV/AIDS Attending Antiretroviral Therapy (ART) Center in North India.印度北部接受抗逆转录病毒治疗(ART)中心治疗的艾滋病毒/艾滋病患者对COVID-19及其他疫苗的认知与犹豫情况。
Indian J Community Med. 2023 May-Jun;48(3):492-496. doi: 10.4103/ijcm.ijcm_901_22. Epub 2023 May 30.
7
Invasive Pneumococcal Disease in People Living with HIV: A Retrospective Case-Control Study in Brazil.巴西艾滋病毒感染者的侵袭性肺炎球菌疾病:一项回顾性病例对照研究
Trop Med Infect Dis. 2023 Jun 19;8(6):328. doi: 10.3390/tropicalmed8060328.
8
Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland.爱尔兰艾滋病毒感染者人口统计学特征和疫苗可预防疾病免疫力的变化。
BMC Infect Dis. 2022 Jun 29;22(1):582. doi: 10.1186/s12879-022-07487-z.
9
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV.益生菌混合物补充对 HIV 感染者 13 价肺炎球菌结合疫苗免疫应答的影响。
Nutrients. 2021 Dec 9;13(12):4412. doi: 10.3390/nu13124412.
10
Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV.妊娠期或产后 HIV 感染妇女接种结合疫苗和多糖疫苗的免疫原性。
J Infect Dis. 2022 Mar 15;225(6):1021-1031. doi: 10.1093/infdis/jiab567.